Kerendia (finerenone) — Point32Health

Initial criteria

• Patient age ≥ 18 years
• Patient has type 2 diabetes (T2D)
• Patient has chronic kidney disease (CKD)
• Patient is currently taking, or has had trial and failure, inadequate response, intolerance, or contraindication to at least ONE medication in the following classes: angiotensin-converting enzyme inhibitor (ACEi) OR angiotensin II receptor blocker (ARB)
• Patient is currently taking, or has had trial and failure, inadequate response, intolerance, or contraindication to a sodium-glucose cotransporter 2 (SGLT2) inhibitor (e.g., Farxiga, Jardiance)